Chlorobenzene

Chlorobenzene

SCHEMBL3023979

Cc1ccc([S@](=O)(O)=S)cc1.Clc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
KDM4E B2RXH2 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
LMNA P02545 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
RECQL P46063 1/20 0.44
ALOX12 P18054 2/20 0.43
GAA P10253 3/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338046 0.86 GAA (0.56) ALDH1A1MAPTCA12CA9CA1
SCHEMBL3818649 0.86 GAA (0.56) ALDH1A1MAPTCA12CA9CA1
Potassium SCHEMBL367653 0.84 GAA (0.54) ALDH1A1MAPTCA12CA9CA1
Benzenethiol SCHEMBL8487581 0.84 CA12 (0.43) ALDH1A1KDM4ETDP1CA12CA9
SCHEMBL7536151 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKDM4ECA12CA9
SCHEMBL10953697 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKDM4ECA12CA9
Propane SCHEMBL3021103 0.80 GAA (0.50) ALDH1A1MAPTCA12CA9CA1
P-Toluenesulfonamide SCHEMBL28704205 0.79 CA1 (0.69) CA12CA9CA1CA2
SCHEMBL6603175 0.78 CA2 (0.53) ALDH1A1MAPTKDM4ECA12CA9
SCHEMBL588340 0.77 SMN1; SMN2 (0.62) ALDH1A1KDM4ETDP1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222407-B2 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position KYORIN PHARMACEUTICAL CO., LTD. (JP) 2012-07-17 US disclosed
US-20100197909-A1 MUTILIN DERIVATIVE HAVING HETEROCYCLIC AROMATIC RING CARBOXYLIC ACID STRUCTURE IN SUBTITUENT AT 14-POSITION KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-08-05 US disclosed
EP-2149571-A1 MUTILIN DERIVATIVE HAVING HETEROCYCLIC AROMATIC RING CARBOXYLIC ACID STRUCTURE IN SUBSTITUENT AT 14-POSITION Kyorin Pharmaceutical Co., Ltd. (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197909-A1 MUTILIN DERIVATIVE HAVING HETEROCYCLIC AROMATIC RING CARBOXYLIC ACID STRUCTURE IN SUBTITUENT AT 14-POSITION PELP1, MLN, SND1 ALDH1A1 1380/4885MAPT 3194/4885KDM4E 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.